Average Co-Inventor Count = 13.93
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (14 from 329 patents)
2. Eli Lilly and Company (1 from 4,442 patents)
15 patents:
1. 11998545 - Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
2. 11780835 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
3. 11648243 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
4. 11634417 - Protein tyrosine phosphatase inhibitors
5. 11247990 - Bicyclic fused pyridine compounds as inhibitors of TAM kinases
6. 11104676 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
7. 10953005 - Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
8. 10881652 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
9. 10555944 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
10. 10441581 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
11. 10172845 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
12. 10172851 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
13. 10144734 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
14. 10137124 - Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
15. 10112942 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors